维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Ponti E"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Role of HIF-1 and NF-B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals显示文摘	Tacchini L Gammella E De Ponti C	2008	J Biol Chem2008，283，20：	1
2	Treatment of macro-re- entrant atrial tachycardia based on electroanatomic mapping: identifi-cation and ablation of the mid-diastolic isthmus 显示文摘	De Ponti R Verlato R Bertaglia E	2007	Europace2007，9，7：	1
3	Sucrose synthase expression during cold acclimation in wheat显示文摘	Crespi M D Zabaleta E J Pontis H G Salerno G L		0，，：	1
4	Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes:an overview显示文摘	de Ponti F Poluzzi E Cavalli A	2002	Drug Saf2002，25，4：	1
5	Targeting the arrhythmo-genic substrate in atrial fibrillation:focus on structural re-modeling显示文摘	Raschi E Boriani G De Ponti F		0，，2：	1
6	Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals显示文摘	TACCHINI L GAMMELLA E de PONTI C	2008	J Biol Chem2008，283，20：	1
7	Toward a pharmacophore for drugs inducing the lon QT syndrome 显示文摘	Cavalli A Poluzzi E De Ponti F	2002	J Med Chem2002，45，18：	1
8	Evaluation of serrated intra- prostatic gold coils positional stability using on-board cone beam compu ted tomography scans acquired throughout the radiation treatment course显示文摘	MICELI R INGROSSO G PONTI E	2015	Pract Radiat Oncol2015，50，15：	1
9	QT-interval prolongation bynon-cardiac drugs:lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
10	In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay 显示文摘	Guillamet E Creus A Ponti J	2004	Mutagenesis2004，19，2：	1
11	QTc and psychotropic drugs显示文摘	De Ponti F Poluzzi E Montanaro N		0，，：	1
12	HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNF-α activation显示文摘	Gibellini D De Crignis E Ponti C	2008	J Med Virol2008，80，9：	1
13	Montanoro N QT interval prolongadon by cardiac or noncardiac factors显示文摘	De Ponti F Poluzzi E	2002	Eur J Clin Pharmacol2002，57，1：	1
14	Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview显示文摘	De Ponti F Poluzzi E Cavalli A	2002	Drug Saf2002，25，4：	1
15	The A19G polymorphism in the 5' untranslated region of the human obese gene does not affect leptin levels in severely obese patients 显示文摘	Lucantoni R Ponti E Berselli ME	2000	J Clin Endocrinol Metab2000，85，10：	1
16	QT-interval prolongation by non-cardiac drugs:lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
17	Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers显示文摘	Cavalli A Poluzzi E De Ponti F	2002	J Med Chem2002，45，18：	1
18	QT interval prolongation by non-cardiac drugs: lessons to be learned from recent experience显示文摘	De Ponti F Poluzzi E Montanaro N	2000	Eur J Clin Pharmacol2000，56，1：	1
19	hERG-related drug toxicity and models for predicting hERG liability and QT prolongation显示文摘	Raschi E Ceccarini L De Ponti F	2009	Drug Metab Toxicol2009，5，9：	1
20	Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs:a call for consensus显示文摘	Ponti F Poluzzi E Montanaro N	2001	Eur J Clin Pharmacol2001，57，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示